Human milk oligosaccharides (HMO) are a group of bioactive carbohydrates found in human breast milk. Emerging research suggests that HMOs could benefit immune functions, gut health, and cognition. HMO consumption has also been associated with fewer respiratory and gastrointestinal illnesses in breastfed infants. This study will investigate the effect of feeding an infant formula and toddler drink that includes HMOs.
In the study, some infants may be eligible to receive an investigational milk-based formula at no cost for one year. Eligible participants may also be provided an investigational toddler drink for a year.
- Must be a newborn age 0 to 14 days when joining
- Must have weighed at least 5 lbs. 8oz. at birth
- Must have been a singleton from a full-term birth (gestational age 37 to 42 weeks)
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (GA, LA), (712) 639-6200 (Grand Island + Hastings, NE), or (402) 934-7563 (Lincoln, NE).
Submit your information
- Macon: Meridian Clinical Research, 5300 Bowman Rd., Macon, GA 31210
- Baton Rouge: Meridian Clinical Research, 8040 Goodwood Blvd., Baton Rouge, LA 70806
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.